Literature DB >> 34139069

Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with COVID-19 without hydroxychloroquine use: Report of the first case.

Mehmet Fatih Atak1, Banu Farabi2, Atiye Akbayrak3, Mehmet Berati Kalelioğlu4, Babar K Rao2.   

Abstract

Entities:  

Keywords:  AGEP; COVID-19; acute generalized exanthematous pustulosis; cutaneous adverse event; favipiravir

Year:  2021        PMID： 34139069     DOI： 10.1111/jocd.14304

Source DB:  PubMed          Journal:  J Cosmet Dermatol        ISSN： 1473-2130            Impact factor:   2.696


× No keyword cloud information.
  2 in total

1.  Acute Generalized Exanthematous Pustulosis following SARS-CoV-2 Virus: Remdesivir as a Suspected Culprit.

Authors:  Fatemeh Mohaghegh; Parvaneh Hatami; Zeinab Aryanian; Farahnaz Fatemi; Zeinab Mohseni Afshar
Journal:  Case Rep Med       Date:  2022-08-10

Review 2.  Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients.

Authors:  Enriqueta Vallejo-Yagüe; Adrian Martinez-De la Torre; Omar S Mohamad; Shweta Sabu; Andrea M Burden
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.